Aceclidine/Tropicamide

醋克利定/托品卡胺

Report date: 2023/05/20 20:00:21

Base Information

Drug NameAceclidine/Tropicamide
Drug Alias NameTropicamide+aceclidine醋克利定+托品卡胺Tropicamide/aceclidineAceclidine+TropicamidePRX-100
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPresbyopia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes TropicamideAceclidine hydrochloride
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPresbyopia Therapies Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLenz Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPresbyopia

Other Information

ATC CodeN/A
Related LinksN/A